WS Investor
09 Apr 2026, 19:30
Thermo Fisher Partners with Singapore Biobank to Advance Proteomics Research
Thermo Fisher Scientific announced a strategic collaboration with Precision Health Research Singapore to support the PRECISE-SG100K study, a major population-scale biobank initiative.
The partnership will deploy advanced proteomics technologies to analyze large-scale biological data, aiming to improve disease detection, patient stratification, and personalized healthcare. The study involves over 100,000 participants and is one of Southeast Asia’s largest health research programs.
Thermo Fisher will integrate multiple proteomic platforms to generate high-resolution data, enabling researchers to uncover disease mechanisms and identify biomarkers more efficiently.
The collaboration reflects growing global investment in biobanks and AI-driven analytics as tools to advance precision medicine and long-term population health outcomes.
Business Wire
Thermo Fisher Scientific announced a strategic collaboration with Precision Health Research Singapore to support the PRECISE-SG100K study, a major population-scale biobank initiative.
The partnership will deploy advanced proteomics technologies to analyze large-scale biological data, aiming to improve disease detection, patient stratification, and personalized healthcare. The study involves over 100,000 participants and is one of Southeast Asia’s largest health research programs.
Thermo Fisher will integrate multiple proteomic platforms to generate high-resolution data, enabling researchers to uncover disease mechanisms and identify biomarkers more efficiently.
The collaboration reflects growing global investment in biobanks and AI-driven analytics as tools to advance precision medicine and long-term population health outcomes.
Business Wire
